[Skip to Content]
[Skip to Content Landing]
February 15, 1980


JAMA. 1980;243(7):631. doi:10.1001/jama.1980.03300330009008

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


In a recent JAMA MEDICAL NEWS story on premarket approval of class III medical devices by the Food and Drug Administration (242:2749-2753, 1979), the name of one device was incorrectly spelled and the manufacturer's name was incorrectly given.

The biochemical test to detect Neisseria gonorrhoeae in male urethral discharge is Gonodecten, and it is manufactured by the United States Packaging Corp Inc, Medical Products Division, La Porte, Ind.